SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-020692
Filing Date
2024-05-20
Accepted
2024-05-20 16:18:41
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1171094
2 ex31-1.htm EX-31.1 17954
3 ex31-2.htm EX-31.2 18642
4 ex32-1.htm EX-32.1 8653
5 ex32-2.htm EX-32.2 8713
  Complete submission text file 0001493152-24-020692.txt   6609588

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nrxs-20240331.xsd EX-101.SCH 50861
7 XBRL CALCULATION FILE nrxs-20240331_cal.xml EX-101.CAL 54815
8 XBRL DEFINITION FILE nrxs-20240331_def.xml EX-101.DEF 231716
9 XBRL LABEL FILE nrxs-20240331_lab.xml EX-101.LAB 430621
10 XBRL PRESENTATION FILE nrxs-20240331_pre.xml EX-101.PRE 351124
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1089776
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

IRS No.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41775 | Film No.: 24964756
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)